Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Non-cash Items: 2019-2024

Historic Non-cash Items for Eton Pharmaceuticals (ETON) over the last 5 years, with Dec 2024 value amounting to $51.3 million.

  • Eton Pharmaceuticals' Non-cash Items fell 60.90% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 60.90%. This contributed to the annual value of $51.3 million for FY2024, which is 1325.05% up from last year.
  • As of FY2024, Eton Pharmaceuticals' Non-cash Items stood at $51.3 million, which was up 1,325.05% from $3.6 million recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Non-cash Items registered a high of $51.3 million during FY2024, and its lowest value of $2.7 million during FY2021.
  • Over the past 2 years, Eton Pharmaceuticals' median Non-cash Items value was $27.5 million (recorded in 2023), while the average stood at $27.5 million.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Non-cash Items soared by 1,478.35% in 2020, and later plummeted by 76.48% in 2021.
  • Yearly analysis of 4 years shows Eton Pharmaceuticals' Non-cash Items stood at $11.5 million in 2020, then tumbled by 76.48% to $2.7 million in 2021, then reached $3.6 million in 2023, then spiked by 1,325.05% to $51.3 million in 2024.